SuVax™ and MarVax™ Thermostable Vaccine Platfo

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

Related Keywords

Ghana , United States , White House , District Of Columbia , Hawaii , Tanzania , Sudan , Uganda , Equatorial Guinea , Mexico , Hawaiians , American , Los Cabos , Axel Lehrer , Soligenix Inc , Linkedin , Centers For Disease , Vaccine Technology , Exchange Commission , Twitter , Johna Burns School Medicine , Us Congress , Our Public Health Solutions , Vaccine Technology Ix Conference , Company Public Health Solutions , Vaccine Technology Conference , National Institute Of Allergy , Johna Burns School Of Medicine , Nasdaq , Defense Threat Reduction Agency , Drug Administration , Biomedical Advanced Research , Development Authority , University Of Hawai , Professor Axel Lehrer , Sudan Ebola , Marburg Virus Vaccine , Public Health Solutions , Generally Recognized , Orphan Drug Designation , Advancing Vaccine Technologies , Generally Regarded , United States Food , Biologics License Application , Filovirus Infection , Virus Disease , Marburg Virus Disease , Disease Control , Ebola Virus Disease , Sudan Virus , Pandemic Preparedness , Transforming Our , School Medicine , National Institute , Infectious Diseases , Project Bioshield , Priority Review Voucher ,